
### [MONDO:0002714](http://purl.obolibrary.org/obo/MONDO_0002714)
**Label:** central nervous system cancer

**Subclasses:** [MONDO:0009837](http://purl.obolibrary.org/obo/MONDO_0009837) (choroid plexus papilloma), [MONDO:0016642](http://purl.obolibrary.org/obo/MONDO_0016642) (meningioma (disease)), [MONDO:0016722](http://purl.obolibrary.org/obo/MONDO_0016722) (pineoblastoma), [MONDO:0016733](http://purl.obolibrary.org/obo/MONDO_0016733) (ganglioglioma), [MONDO:0005499](http://purl.obolibrary.org/obo/MONDO_0005499) (brain glioma), [MONDO:0020560](http://purl.obolibrary.org/obo/MONDO_0020560) (atypical teratoid rhabdoid tumor), [MONDO:0018177](http://purl.obolibrary.org/obo/MONDO_0018177) (glioblastoma (disease)), [MONDO:0013093](http://purl.obolibrary.org/obo/MONDO_0013093) (glioma susceptibility 3), [MONDO:0017582](http://purl.obolibrary.org/obo/MONDO_0017582) (pituitary carcinoma (disease)), [MONDO:0007959](http://purl.obolibrary.org/obo/MONDO_0007959) (medulloblastoma), [MONDO:0016715](http://purl.obolibrary.org/obo/MONDO_0016715) (ependymoblastoma), 

**Corr. equiv. classes:** [Orphanet:360](http://www.orpha.net/ORDO/Orphanet_360), [Orphanet:251909](http://www.orpha.net/ORDO/Orphanet_251909), [Orphanet:2807](http://www.orpha.net/ORDO/Orphanet_2807), [OMIM:155255](http://purl.obolibrary.org/obo/OMIM_155255), [Orphanet:251949](http://www.orpha.net/ORDO/Orphanet_251949), [OMIM:137800](http://purl.obolibrary.org/obo/OMIM_137800), [Orphanet:300385](http://www.orpha.net/ORDO/Orphanet_300385), [Orphanet:251858](http://www.orpha.net/ORDO/Orphanet_251858), [Orphanet:251867](http://www.orpha.net/ORDO/Orphanet_251867), [Orphanet:251899](http://www.orpha.net/ORDO/Orphanet_251899), [OMIM:606190](http://purl.obolibrary.org/obo/OMIM_606190), [OMIM:260500](http://purl.obolibrary.org/obo/OMIM_260500), [Orphanet:251863](http://www.orpha.net/ORDO/Orphanet_251863), [Orphanet:2495](http://www.orpha.net/ORDO/Orphanet_2495), [OMIM:613029](http://purl.obolibrary.org/obo/OMIM_613029), [OMIM:613028](http://purl.obolibrary.org/obo/OMIM_613028), [Orphanet:251880](http://www.orpha.net/ORDO/Orphanet_251880), [Orphanet:99966](http://www.orpha.net/ORDO/Orphanet_99966), [Orphanet:616](http://www.orpha.net/ORDO/Orphanet_616), [OMIM:609322](http://purl.obolibrary.org/obo/OMIM_609322), [Orphanet:182067](http://www.orpha.net/ORDO/Orphanet_182067), 

**Class expressions from DL-Learner:**

- [HP:0100836](http://purl.obolibrary.org/obo/HP_0100836) (Malignant neoplasm of the central nervous system) and (not ([HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument))) 56.55%
- [HP:0100836](http://purl.obolibrary.org/obo/HP_0100836) (Malignant neoplasm of the central nervous system) and (not ([HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin))) 52.02%
- [HP:0100836](http://purl.obolibrary.org/obo/HP_0100836) (Malignant neoplasm of the central nervous system) and (not ([HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face))) 49.74%
- [HP:0002315](http://purl.obolibrary.org/obo/HP_0002315) (Headache) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) and [HP:0100006](http://purl.obolibrary.org/obo/HP_0100006) (Neoplasm of the central nervous system) 49.64%
- [HP:0100836](http://purl.obolibrary.org/obo/HP_0100836) (Malignant neoplasm of the central nervous system) and (not ([HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe))) 48.75%
- [HP:0100836](http://purl.obolibrary.org/obo/HP_0100836) (Malignant neoplasm of the central nervous system) and (not ([HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology))) 48.75%
- [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) and [HP:0100006](http://purl.obolibrary.org/obo/HP_0100006) (Neoplasm of the central nervous system) 48.25%
- [HP:0100006](http://purl.obolibrary.org/obo/HP_0100006) (Neoplasm of the central nervous system) 47.78%
- [HP:0002315](http://purl.obolibrary.org/obo/HP_0002315) (Headache) and [HP:0100006](http://purl.obolibrary.org/obo/HP_0100006) (Neoplasm of the central nervous system) 47.02%
- [HP:0100836](http://purl.obolibrary.org/obo/HP_0100836) (Malignant neoplasm of the central nervous system) and (not ([HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system))) 45.91%
- [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) and [HP:0100006](http://purl.obolibrary.org/obo/HP_0100006) (Neoplasm of the central nervous system) 45.77%
- [HP:0100836](http://purl.obolibrary.org/obo/HP_0100836) (Malignant neoplasm of the central nervous system) and (not ([HP:0000315](http://purl.obolibrary.org/obo/HP_0000315) (Abnormality of the orbital region))) 45.53%
- [HP:0004375](http://purl.obolibrary.org/obo/HP_0004375) (Neoplasm of the nervous system) 44.97%
- [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) and [HP:0100006](http://purl.obolibrary.org/obo/HP_0100006) (Neoplasm of the central nervous system) 44.90%
- [HP:0002118](http://purl.obolibrary.org/obo/HP_0002118) (Abnormality of the cerebral ventricles) and [HP:0100006](http://purl.obolibrary.org/obo/HP_0100006) (Neoplasm of the central nervous system) 43.99%


